Buscar
Congreso SOLACI
HomeCoronary diseaseDrug-eluting stents

Drug-eluting stents

Ver Categoría

Chronic Ischemic cardiopathy

Early and Late Outcomes with the ABSORB Bioresorbable Scaffold

Coronary angioplasty with drug-eluting stents (DES) is associated with a 2-3% annual incidence of stent-related events, a...
Dr. Andrés Rodríguez -
Ver más
Acute coronary syndromes

DCB-BIF Trial: Randomized Study of Side Branch Drug-Coated Balloon Angioplasty Following Provisional Stenting

Coronary bifurcations present technical challenges that should be addressed for adequate coronary geometry. The first treatment option...
Dr. Omar Tupayachi -
Ver más
Coronary disease

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation...
Dr. Carlos Fava -
Ver más
Coronary Disease

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to...
Dr. Andrés Rodríguez -
Ver más
Coronary disease

Paclitaxel-Eluting vs. Sirolimus-Eluting Balloons

Coronary restenosis remains one of the main challenges in percutaneous transluminal coronary angioplasty (PTCA), especially nowadays, when...
Dr. Carlos Fava -
Ver más
Acute coronary syndromes

Results of the PROSPECT II Substudy: Relationship Between In-Stent or Stent Edge-Related Lipid-Rich Plaque and Adverse Clinical Events After PCI in Patients with MI

The use of drug-eluting stents and the integration of intravascular imaging techniques have reduced the risk of...
Dr. Andrés Rodríguez -
Ver más
Antiplatelet

Ultrathin vs Thin-Strut Stents in PCI Patients at High Bleeding Risk

Several in vivo studies have shown that ultrathin stents present lower thrombogenic risk vs. thin-strut stents, which...
Dr. Andrés Rodríguez -
Ver más
Coronary disease

SCAAR Registry: Coronary Angioplasty in Venous Grafts

Most patients undergoing coronary artery bypass graft (CABG) benefit from at least one saphenous vein graft (SVG)....
Dr. Carlos Fava -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

Dr. Andrés Rodríguez - 0
The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Dr. Omar Tupayachi - 0
Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

TAVR Unload: TAVR in Moderate Aortic Stenosis and Ventricular Function Deterioration

Dr. Omar Tupayachi - 0
Aortic Stenosis (AS) significantly contributes to valvulo-arterial impedance in patients with heart failure and reduced ejection fraction (HFrEF), making it a relevant therapeutic target...

Noticias Institucionales

Uruguay Sessions 2025 | Young Interventional Cardiologists Contest

solaci - 0
Call for Case Submission LI SOLACI Regional Sessions – 16° Southern Cone  It is with great pleasure that we hereby invite all young Latin American cardiologists...

Watch Angioplasty Techniques for Bifurcations Again From a Completely Different Perspective.

solaci - 0
You can now watch on our YouTube channel the event we held in collaboration with Medtronic, titled: "Visualizations of Different PCI Techniques for Bifurcations...

2025 SOLACI Research Grant

solaci - 0
By initiative of the board of directors (together with the research department), SOLACI is launching a research grant aimed at improving knowledge and access...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad